SCHEMBL28027088

SCHEMBL28027088

Nc1ncccn1.OB(O)Oc1ccncc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ KCNA1 Q09470 1/20 0.33
▸ APAF1 O14727 1/20 0.32
▸ PRKCI P41743 1/20 0.32
▸ CYP19A1 P11511 1/20 0.31
▸ MAP4K4 O95819 1/20 0.30
▸ SCN9A Q15858 1/20 0.30
▸ NOS3 P29474 1/20 0.30
▸ NOS1 P29475 1/20 0.30
▸ NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1443103 0.84 HSD17B10 (0.37) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL28999416 0.73 CYP1A2 (0.33) SMN1; SMN2LMNACYP2D6CYP19A1
Pyridine SCHEMBL28078344 0.72 TSHR (0.39) SMN1; SMN2MEN1KMT2ALMNATSHR
SCHEMBL14655772 0.72 MAPT (0.48) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL16610671 0.71 HDAC1 (0.39) HSP90AA1
SCHEMBL29197129 0.71 NPC1 (0.48) SMN1; SMN2ALDH1A1TSHR
SCHEMBL30788428 0.69 NOS3 (0.57) MEN1KMT2ASCN9ANOS3NOS1
SCHEMBL28485239 0.69 CYP19A1 (0.43) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
Hydrogen Peroxide SCHEMBL28125104 0.67 — —
SCHEMBL3800806 0.67 CA1 (0.38) MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104837829-A Inhibitor compounds CANCER REC TECH LTD 2015-08-12 — — CN disclosed
Send feedback